BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31825103)

  • 1. An efflux inhibitor of the MacAB pump in Salmonella enterica serovar Typhimurium.
    Yamagishi A; Nakano S; Yamasaki S; Nishino K
    Microbiol Immunol; 2020 Mar; 64(3):182-188. PubMed ID: 31825103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ABC-type efflux pump MacAB protects Salmonella enterica serovar typhimurium from oxidative stress.
    Bogomolnaya LM; Andrews KD; Talamantes M; Maple A; Ragoza Y; Vazquez-Torres A; Andrews-Polymenis H
    mBio; 2013 Oct; 4(6):e00630-13. PubMed ID: 24169575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linearized Siderophore Products Secreted via MacAB Efflux Pump Protect Salmonella enterica Serovar Typhimurium from Oxidative Stress.
    Bogomolnaya LM; Tilvawala R; Elfenbein JR; Cirillo JD; Andrews-Polymenis HL
    mBio; 2020 May; 11(3):. PubMed ID: 32371597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ABC-Type Efflux Pump MacAB Is Involved in Protection of Serratia marcescens against Aminoglycoside Antibiotics, Polymyxins, and Oxidative Stress.
    Shirshikova TV; Sierra-Bakhshi CG; Kamaletdinova LK; Matrosova LE; Khabipova NN; Evtugyn VG; Khilyas IV; Danilova IV; Mardanova AM; Sharipova MR; Bogomolnaya LM
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33692192
    [No Abstract]   [Full Text] [Related]  

  • 5. Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium.
    Nishino K; Latifi T; Groisman EA
    Mol Microbiol; 2006 Jan; 59(1):126-41. PubMed ID: 16359323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in the MacAB-TolC efflux pump influences pathogenesis of invasive Salmonella isolates from Africa.
    Honeycutt JD; Wenner N; Li Y; Brewer SM; Massis LM; Brubaker SW; Chairatana P; Owen SV; Canals R; Hinton JCD; Monack DM
    PLoS Pathog; 2020 Aug; 16(8):e1008763. PubMed ID: 32834002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of medicinal plants from North Western Himalayas as an efflux pump inhibitor against MDR AcrAB-TolC Salmonella enterica serovar typhimurium: In vitro and In silico studies.
    Mehta J; Rolta R; Dev K
    J Ethnopharmacol; 2022 Jan; 282():114589. PubMed ID: 34492321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efflux Pump Overexpression Contributes to Tigecycline Heteroresistance in
    Chen Y; Hu D; Zhang Q; Liao XP; Liu YH; Sun J
    Front Cell Infect Microbiol; 2017; 7():37. PubMed ID: 28261566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efflux proteins MacAB confer resistance to arsenite and penicillin/macrolide-type antibiotics in Agrobacterium tumefaciens 5A.
    Shi K; Cao M; Li C; Huang J; Zheng S; Wang G
    World J Microbiol Biotechnol; 2019 Jul; 35(8):115. PubMed ID: 31332542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar typhimurium DT204 acrB mutants selected with fluoroquinolones.
    Olliver A; Vallé M; Chaslus-Dancla E; Cloeckaert A
    Antimicrob Agents Chemother; 2005 Jan; 49(1):289-301. PubMed ID: 15616308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TolC dependency of multidrug efflux systems in Salmonella enterica serovar Typhimurium.
    Horiyama T; Yamaguchi A; Nishino K
    J Antimicrob Chemother; 2010 Jul; 65(7):1372-6. PubMed ID: 20495209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype microarray analysis of the drug efflux systems in Salmonella enterica serovar Typhimurium.
    Yamasaki S; Fujioka T; Hayashi K; Yamasaki S; Hayashi-Nishino M; Nishino K
    J Infect Chemother; 2016 Nov; 22(11):780-784. PubMed ID: 27210311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of AcrB Efflux Function Confers Loss of Virulence on
    Wang-Kan X; Blair JMA; Chirullo B; Betts J; La Ragione RM; Ivens A; Ricci V; Opperman TJ; Piddock LJV
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-NS modulates multidrug resistance of Salmonella enterica serovar Typhimurium by repressing multidrug efflux genes acrEF.
    Nishino K; Hayashi-Nishino M; Yamaguchi A
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3541-3. PubMed ID: 19506059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loxapine, an antipsychotic drug, suppresses intracellular multiple-antibiotic-resistant Salmonella enterica serovar Typhimurium in macrophages.
    Yang CY; Hsu CY; Fang CS; Shiau CW; Chen CS; Chiu HC
    J Microbiol Immunol Infect; 2019 Aug; 52(4):638-647. PubMed ID: 31239204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of the multidrug efflux pump and lipopolysaccharides in the intrinsic antibiotic resistance of Salmonella enterica serovar Typhimurium.
    Yamasaki S; Nagasawa S; Fukushima A; Hayashi-Nishino M; Nishino K
    J Antimicrob Chemother; 2013 May; 68(5):1066-70. PubMed ID: 23378414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commonly used farm disinfectants can select for mutant Salmonella enterica serovar Typhimurium with decreased susceptibility to biocides and antibiotics without compromising virulence.
    Randall LP; Cooles SW; Coldham NG; Penuela EG; Mott AC; Woodward MJ; Piddock LJ; Webber MA
    J Antimicrob Chemother; 2007 Dec; 60(6):1273-80. PubMed ID: 17897935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
    Zheng J; Cui S; Meng J
    J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of global regulator Rma for multidrug efflux-mediated fluoroquinolone resistance in Salmonella.
    Feuerriegel S; Heisig P
    Microb Drug Resist; 2008 Dec; 14(4):259-63. PubMed ID: 19018673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness.
    Karatzas KA; Webber MA; Jorgensen F; Woodward MJ; Piddock LJ; Humphrey TJ
    J Antimicrob Chemother; 2007 Nov; 60(5):947-55. PubMed ID: 17855722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.